Advertisement
Screener

Cinctive Capital Management LP Historic Quarter Change: Foreign ADRs, Sold Out

Cinctive Capital Management LP historic quarter change: Foreign ADRs, Sold out

In depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), over 10 quarters from 2023-12-31 to 2026-06-30, Cinctive Capital Management LP opened 7 positions, added to 4, reduced 5 and sold out of 9.

  • Q1 2026: Stock ASTRAZENECA PLC; Country of operation —; Class SPONSORED ADR; Shares before 4,079.
  • Q4 2025: Stock ASCENDIS PHARMA A/S; Country of operation —; Class SPONSORED ADR; Shares before 8,376.
  • Q3 2025: Stock JAMES HARDIE INDS PLC; Country of operation —; Class SPONSORED ADR; Shares before 193,379.
  • Q1 2025: Stock TOTALENERGIES SE; Country of operation —; Class SPONSORED ADS; Shares before 13,500.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1787258), 10 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-14); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-12); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2019-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q1 2026ASTRAZENECA PLC
CUSIP 046353108
SPONSORED ADR4,0790-4,079$374,982$0-$374,9822026-05-15
Q4 2025ASCENDIS PHARMA A/S
CUSIP 04351P101
SPONSORED ADR8,3760-8,376$1,665,233$0-$1,665,2332026-02-17
Q3 2025JAMES HARDIE INDS PLC
CUSIP 47030M106
SPONSORED ADR193,3790-193,379$5,199,961$0-$5,199,9612025-11-14
Q1 2025TOTALENERGIES SE
CUSIP 89151E109
SPONSORED ADS13,5000-13,500$735,750$0-$735,7502025-05-15
Q4 2024ASCENDIS PHARMA A/S
CUSIP 04351P101
SPONSORED ADR11,2710-11,271$1,682,873$0-$1,682,8732025-02-12
Q2 2024OLINK HLDG AB
CUSIP 680710100
SPONSORED ADS79,2630-79,263$1,863,473$0-$1,863,4732024-08-14
Q2 2024AVADEL PHARMACEUTICALS PLC
CUSIP 05337M104
SPONSORED ADR21,7490-21,749$367,341$0-$367,3412024-08-14
Q1 2024ASTRAZENECA PLC
CUSIP 046353108
SPONSORED ADR18,0580-18,058$1,216,206$0-$1,216,2062024-05-15
Q1 2024OATLY GROUP AB
CUSIP 67421J108
SPONSORED ADS157,6120-157,612$185,982$0-$185,9822024-05-15

Similar Firms

Firm NameCountry13F ValueHoldings
Meridiem Capital Partners LPUnited States$1.534B64
Irenic Capital Management LPUnited States$1.535B47
FJ Investments, LLCUnited States$1.534B6
Great Hill Capital LLCUnited States$1.536B47
FULTON BREAKEFIELD BROENNIMAN LLCUnited States$1.533B200
Sienna GestionFrance$1.533B136
Clean Energy Transition LLPUnited Kingdom$1.537B15
SAGE FINANCIAL GROUP INCUnited States$1.537B107
HOWE & RUSLING INCUnited States$1.532B529
Cryder Capital Partners LLPUnited Kingdom$1.531B10